Sirona Biochem Corp. (SRBCF) 0.1040 $SRBCF
Sirona Grant Stock Options
Marketwire - Fri Apr 25, 6:00PM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) (the "Company"
announces that is has granted incentive stock options under its stock option plan to a director and officer of the company for the purchase of 750,000 common shares of the Company at a price of $0.11 per share for a period of five years.
Sirona Biochem Announces Collaboration With Magellan BioScience
Marketwire - Wed Apr 23, 8:39AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) is pleased to announce a collaboration with Magellan BioScience Group, Inc. The goal of the collaboration is to prioritize technologies discovered or identified by Magellan BioScience which require Sirona Biochem's expertise in stabilization for safe and effective commercial applications. Target markets for potential applications include pharmaceutical, cosmetic, and over the counter (OTC) consumer packaged goods.
Sirona Engages Torrey Hills Capital
Marketwire - Thu Apr 17, 6:45AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB), (the "Company" is pleased to announce that it has retained the services of San Diego Torrey Hills Capital, Inc. ("Torrey Hills ", a Rancho Santa Fe, California based investor relations firm, to provide market awareness and investor relations services to the Company, subject to TSX Venture Exchange acceptance. Torrey Hills will develop and manage a comprehensive finance and investor relations campaign for the Company including building and maintaining an investor audience, increasing awareness of the Company in the investor community and coordinating communication with management and investment professionals.
Sirona Biochem Announces Patent for Anti-Aging Family of Compounds
Marketwire - Tue Apr 01, 6:45AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM.V) (OTCQX: SRBCF) (FRANKFURT: ZSB) is pleased to announce that a new patent application has been deposited by its subsidiary TFChem for a second generation of glycoprotein compounds. The first target marketplace for this technology will be anti-aging cosmetics. Future applications may include consumer packaged goods and prescription pharmaceuticals.
Sirona Biochem Announces Jacques Cousteau's Son and Grandson as Brand Ambassadors
Marketwire - Thu Mar 27, 6:47AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) is pleased to announce that Jean-Michel Cousteau and Fabien Cousteau (son and grandson of Jacques Cousteau) will become Brand Ambassadors for the Company. A formal Brand Ambassador launch event has been scheduled for April 8, 2014 at TFChem in Val de Reuil, France.
Sirona Biochem Welcomes Claude Nivet, New Laboratory Operations Manager at TFChem
Marketwire - Fri Mar 21, 5:55PM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB) Sirona Biochem is pleased to announce that Claude Nivet has joined TFChem in the newly created position of Laboratory Operations Manager. Claude's responsibilities include leading the plan to expand TFChem's physical structure and scientific team.
Sirona Biochem Closes Private Placement
Marketwire - Thu Mar 06, 4:26PM CST
Sirona Biochem Corp. (TSX-V: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) (the "Company" is pleased to announce that it has closed its private placement in the amount of 9,230,770 units at $0.13 per unit for total gross proceeds of $1,200,000. Each unit consists of one common share and one transferable share purchase warrant, each warrant exercisable into one additional common share of the Company for a period of three years from the date of issue at a price of $0.20 per share.
Sirona Arranges $1.2M Private Placement
Marketwire - Tue Feb 25, 3:52PM CST
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) (the "Company" announces that it has arranged, subject to TSX Venture Exchange acceptance, a private placement of 9,230,770 units at $0.13 per unit for total gross proceeds of $1,200,000. Each unit will consist of one common share and one transferable share purchase warrant, each warrant exercisable into one additional common share for a period of three years from the date of issue at a price of $0.20 per share. The private placement is fully subscribed.
Economic Investment Trust Limited Announces Dividend
Marketwire - Wed Feb 12, 12:33PM CST
The Board of Directors of Economic Investment Trust Limited (TSX: EVT) today declared a cash dividend of $7.20 per Common Share payable March 31, 2014 to shareholders of record on March 14, 2014.
DA Saddened By Passing of Ben Skosana [press release]
All Africa Global Media - Wed Feb 12, 12:32PM CST
The Democratic Alliance is saddened by the passing of National Assembly House Chairperson and IFP Member of Parliament, Ben Skosana last night.
Sirona Grant Stock Options
Marketwire - Fri Apr 25, 6:00PM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) (the "Company"
announces that is has granted incentive stock options under its stock option plan to a director and officer of the company for the purchase of 750,000 common shares of the Company at a price of $0.11 per share for a period of five years. Sirona Biochem Announces Collaboration With Magellan BioScience
Marketwire - Wed Apr 23, 8:39AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) is pleased to announce a collaboration with Magellan BioScience Group, Inc. The goal of the collaboration is to prioritize technologies discovered or identified by Magellan BioScience which require Sirona Biochem's expertise in stabilization for safe and effective commercial applications. Target markets for potential applications include pharmaceutical, cosmetic, and over the counter (OTC) consumer packaged goods.
Sirona Engages Torrey Hills Capital
Marketwire - Thu Apr 17, 6:45AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB), (the "Company"
is pleased to announce that it has retained the services of San Diego Torrey Hills Capital, Inc. ("Torrey Hills ", a Rancho Santa Fe, California based investor relations firm, to provide market awareness and investor relations services to the Company, subject to TSX Venture Exchange acceptance. Torrey Hills will develop and manage a comprehensive finance and investor relations campaign for the Company including building and maintaining an investor audience, increasing awareness of the Company in the investor community and coordinating communication with management and investment professionals. Sirona Biochem Announces Patent for Anti-Aging Family of Compounds
Marketwire - Tue Apr 01, 6:45AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM.V) (OTCQX: SRBCF) (FRANKFURT: ZSB) is pleased to announce that a new patent application has been deposited by its subsidiary TFChem for a second generation of glycoprotein compounds. The first target marketplace for this technology will be anti-aging cosmetics. Future applications may include consumer packaged goods and prescription pharmaceuticals.
Sirona Biochem Announces Jacques Cousteau's Son and Grandson as Brand Ambassadors
Marketwire - Thu Mar 27, 6:47AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) is pleased to announce that Jean-Michel Cousteau and Fabien Cousteau (son and grandson of Jacques Cousteau) will become Brand Ambassadors for the Company. A formal Brand Ambassador launch event has been scheduled for April 8, 2014 at TFChem in Val de Reuil, France.
Sirona Biochem Welcomes Claude Nivet, New Laboratory Operations Manager at TFChem
Marketwire - Fri Mar 21, 5:55PM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB) Sirona Biochem is pleased to announce that Claude Nivet has joined TFChem in the newly created position of Laboratory Operations Manager. Claude's responsibilities include leading the plan to expand TFChem's physical structure and scientific team.
Sirona Biochem Closes Private Placement
Marketwire - Thu Mar 06, 4:26PM CST
Sirona Biochem Corp. (TSX-V: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) (the "Company"
is pleased to announce that it has closed its private placement in the amount of 9,230,770 units at $0.13 per unit for total gross proceeds of $1,200,000. Each unit consists of one common share and one transferable share purchase warrant, each warrant exercisable into one additional common share of the Company for a period of three years from the date of issue at a price of $0.20 per share. Sirona Arranges $1.2M Private Placement
Marketwire - Tue Feb 25, 3:52PM CST
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) (the "Company"
announces that it has arranged, subject to TSX Venture Exchange acceptance, a private placement of 9,230,770 units at $0.13 per unit for total gross proceeds of $1,200,000. Each unit will consist of one common share and one transferable share purchase warrant, each warrant exercisable into one additional common share for a period of three years from the date of issue at a price of $0.20 per share. The private placement is fully subscribed. Economic Investment Trust Limited Announces Dividend
Marketwire - Wed Feb 12, 12:33PM CST
The Board of Directors of Economic Investment Trust Limited (TSX: EVT) today declared a cash dividend of $7.20 per Common Share payable March 31, 2014 to shareholders of record on March 14, 2014.
DA Saddened By Passing of Ben Skosana [press release]
All Africa Global Media - Wed Feb 12, 12:32PM CST
The Democratic Alliance is saddened by the passing of National Assembly House Chairperson and IFP Member of Parliament, Ben Skosana last night.
